Scientist
In Part 1 of this series, we examined the evolution of outsourcing in drug discovery. In part II we will examine with deeper focus the specific...
A recent white paper was released that traces the trajectory over the last ten years of 120 independent for-profit startups in the field of...
Antibodies have re-shaped biomedical researches since their discovery. From research tools to therapeutics and diagnostics, antibodies are...
What is RWE? As a relatively new means of conducting research in the life sciences, RWE, or real-world evidence, is data that comes from “real...
What are Public-Private Partnerships for Drug Discovery? In recent decades, the proliferation of world-wide epidemics and health emergencies (such...
This is the third and final post of a series (part 1 and part 2) on directed evolution. What do protein engineers actually produce using directed...
This is Part 4 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...
This is Part 3 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...
This is Part 2 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...
This is Part 1 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...